IE53829B1 - Human proinsulin pharmaceutical formulations - Google Patents

Human proinsulin pharmaceutical formulations

Info

Publication number
IE53829B1
IE53829B1 IE2062/82A IE206282A IE53829B1 IE 53829 B1 IE53829 B1 IE 53829B1 IE 2062/82 A IE2062/82 A IE 2062/82A IE 206282 A IE206282 A IE 206282A IE 53829 B1 IE53829 B1 IE 53829B1
Authority
IE
Ireland
Prior art keywords
human proinsulin
proinsulin
human
insulin
composition
Prior art date
Application number
IE2062/82A
Other languages
English (en)
Other versions
IE822062L (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IE822062L publication Critical patent/IE822062L/xx
Publication of IE53829B1 publication Critical patent/IE53829B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IE2062/82A 1981-08-27 1982-08-26 Human proinsulin pharmaceutical formulations IE53829B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29675281A 1981-08-27 1981-08-27

Publications (2)

Publication Number Publication Date
IE822062L IE822062L (en) 1983-02-27
IE53829B1 true IE53829B1 (en) 1989-03-15

Family

ID=23143402

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2062/82A IE53829B1 (en) 1981-08-27 1982-08-26 Human proinsulin pharmaceutical formulations

Country Status (21)

Country Link
JP (1) JPS5846023A (fr)
AU (1) AU552054B2 (fr)
BE (1) BE894186A (fr)
CA (1) CA1176160A (fr)
CH (1) CH650677A5 (fr)
DE (1) DE3232036A1 (fr)
FR (1) FR2511866B1 (fr)
GB (1) GB2104380B (fr)
HU (1) HU193522B (fr)
IE (1) IE53829B1 (fr)
IL (1) IL66610A (fr)
IT (1) IT1153184B (fr)
LU (1) LU84358A1 (fr)
MW (1) MW3782A1 (fr)
MY (1) MY8700757A (fr)
NL (1) NL8203316A (fr)
NZ (1) NZ201683A (fr)
PH (1) PH18716A (fr)
SE (1) SE8204871L (fr)
ZA (1) ZA826157B (fr)
ZW (1) ZW17382A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
EP0166971B1 (fr) * 1984-06-09 1990-02-28 Hoechst Aktiengesellschaft Préparations d'insuline, procédé pour leur fabrication et leur application
US5034415A (en) * 1987-08-07 1991-07-23 Century Laboratories, Inc. Treatment of diabetes mellitus
US4789660A (en) * 1987-09-10 1988-12-06 American Home Products Corporation Insulin administration using methyl and propyl paraben
ES2331342B1 (es) * 2006-05-22 2010-10-13 Consejo Superior Investg.Cientificas Uso de la proinsulina para la elaboracion de una composicion farmaceutica neuroprotectora, composicion terapeutica que la contiene y sus aplicaciones.
USD1010056S1 (en) * 2020-08-25 2024-01-02 Magpul Industries Corp. Gun sight

Also Published As

Publication number Publication date
HU193522B (en) 1987-10-28
LU84358A1 (fr) 1983-02-28
ZW17382A1 (en) 1982-11-17
IL66610A0 (en) 1982-12-31
FR2511866A1 (fr) 1983-03-04
GB2104380B (en) 1984-12-05
PH18716A (fr) 1985-09-11
ZA826157B (en) 1984-04-25
NL8203316A (nl) 1983-03-16
IL66610A (en) 1985-11-29
FR2511866B1 (fr) 1986-08-14
AU8759582A (en) 1983-03-03
BE894186A (fr) 1983-02-24
IT1153184B (it) 1987-01-14
IT8223019A0 (it) 1982-08-27
MW3782A1 (en) 1984-06-13
JPS5846023A (ja) 1983-03-17
IE822062L (en) 1983-02-27
SE8204871D0 (sv) 1982-08-25
MY8700757A (en) 1987-12-31
CA1176160A (fr) 1984-10-16
NZ201683A (en) 1985-08-16
CH650677A5 (de) 1985-08-15
AU552054B2 (en) 1986-05-22
SE8204871L (sv) 1983-02-28
DE3232036A1 (de) 1983-03-10
GB2104380A (en) 1983-03-09

Similar Documents

Publication Publication Date Title
Orth et al. Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol.
JP4689833B2 (ja) グルカゴン様ペプチド−1の貯蔵安定性製剤
JP4809352B2 (ja) 線維芽細胞成長因子21の突然変異タンパク質
US4652548A (en) Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin
CA1176161A (fr) Composes pharmaceutiques contenant de l'insuline humaine et de la proinsuline
JP2008522617A (ja) 線維芽細胞成長因子21の突然変異タンパク質
US4654324A (en) Human proinsulin pharmaceutical formulations
JPH06505235A (ja) 同化作用のためのigf−iおよびigfbpの組合わせ
CA1176158A (fr) Compose pharmaceutique contenant de l'insuline humaine et un c-peptide humain
CA2527039C (fr) Compositions d'analogues grf et leur utilisation
AU2005297366B2 (en) GH secretagogues and uses thereof
CA1176160A (fr) Compose pharmaceutique de pro-insuline humaine
KR100894364B1 (ko) 특히 안과 용도로 상처와 병소의 회복 및/또는 개선요법에 적합한 아미노산 기초한 조성물
CA1176159A (fr) Compose pharmaceutique contenant de l'insuline humaine, un c-peptide et de la pro-insuline
US6303127B1 (en) Treatment of disease states
KR20220039790A (ko) FGF21 Fc 융합 단백질, GLP-1 Fc 융합 단백질 및 이들의 조합 치료제와 용도
EP0055885A2 (fr) Préparations insuliniques
WO1998041222A1 (fr) Formulations de proteine de l'obesite
Ribeiro Somatrogon. Long-acting human growth hormone, Treatment of human growth hormone deficiency
Das Rapid acting analogues in diabetes mellitus management
JPS59175437A (ja) 高コレステロ−ル血症改善剤
JPH0827024A (ja) 口腔粘膜疾患治療剤